Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.
about
Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapiesNovel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancerCombining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLCTherapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancerPhase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancerA phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinomaProgress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancerThe prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy.A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324.Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trialIncidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients: a systematic review and meta-analysisPhase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma.EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation.A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Incidence and risk of treatment-related mortality with anti-epidermal growth factor receptor monoclonal antibody in cancer patients: a meta-analysis of 21 randomized controlled trials.Cetuximab in non-small-cell lung cancerPhase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancerFeasibility of cetuximab and chemoradiotherapy combination in Chinese patients with unresectable stage III non-small cell lung cancer: a preliminary reportTargeted therapies for non-small cell lung cancer: an evolving landscape.Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials.Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.Mutation and expression of multiple treatment response-related genes in a population with locally advanced non-small cell lung cancer.Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer.Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.Combined radio- and chemotherapy for non-small cell lung cancer: systematic review of landmark studies based on acquired citations.Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer.Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-HEGFR inhibition in non-small cell lung cancer: current evidence and future directionsTreatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung canceConcomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.Therapeutic management options for stage III non-small cell lung cancer.A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancerRational use of cetuximab in the treatment of advanced non-small cell lung cancer.A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
P2860
Q26775388-59A0003A-08E9-4962-B691-D6F7731CC847Q26827571-69CC4C72-BF6F-4DE2-BC59-289B21DEA901Q26852202-249BAFC7-B775-4318-978A-01DFF9645397Q27004357-4336D278-654C-4A7C-9759-A4E4C667CA82Q33410020-4C663AD0-BA4C-4BC0-92CA-60235253E9D4Q33435839-453A5898-B8E4-4BF2-BFFC-65738C3F27B1Q33720025-1516F7BF-DF6D-46FC-BBCE-DB94198EBA55Q33829279-4575781B-1B5F-48FB-A8AE-EECF9C92D47DQ34041735-AA79E8E5-88DE-4BFB-B7D5-B25B550EEA31Q34216725-F5769BB1-402D-4587-8196-9C4E6602643AQ34462689-54237B5A-9716-4072-9400-D9B7AD864C1FQ34503889-53A09704-C852-4FBB-96B6-F69E676D0095Q34537664-3EF41892-C77B-4C14-9444-461E37471A8FQ34633068-C77B9E05-A232-4B7B-9512-3B70C8D49A8BQ34782417-F1FEF0EC-9DF7-4BB3-A849-D65D88B9A936Q35058595-0D8BC612-3087-43C7-9968-B7755D9477CEQ35060785-7F505070-BDAC-4C3A-A524-7882ECE017EEQ35200393-CC6F4EDC-FA75-45C0-9547-73DDDE34672CQ35432484-E35B5A7E-C12D-4D86-B7B4-127E1482646EQ35538759-5EDEA27C-C7F8-4BB4-BC14-1D100ACD51D5Q35628597-163B9CDF-6C61-452E-8EDD-E3F90AA7AA50Q35652853-89A1F9B7-E2C6-40FC-9230-90E9B5BBB6C2Q35820508-8DC96632-704E-418D-98C9-709C947C911EQ35995409-E7EDEC96-7127-406A-B2BC-164AE7040ABFQ36089579-CA7D31F0-BA9B-4ED9-AA3B-6FA05B715072Q36368864-3D833891-0E38-4090-95B4-036827BF41D4Q36507559-CD190298-96C5-45AD-B992-F400B0E9CF57Q36609568-8F4F021C-A850-4675-B6ED-6E986348CC7DQ36946823-967D01F6-EFE0-477F-ACD4-17EB4BB97CC9Q36993644-33279DE5-ABF6-4FB4-AEF4-716C45E5C062Q36999705-E70EB795-DB5C-4AE9-B184-A4CE37F9349BQ37126741-66EBE21A-AA3A-4125-AE65-47076AE104FCQ37136655-09929A1D-5242-47C0-A165-E85AFF1423E7Q37180302-0643731A-A2B3-4F18-B9C4-993E5087728CQ37423919-0EC0C144-42E3-4ECD-A749-B097F2FE96BCQ37605623-5EAA0B9B-DF8C-411A-9C0B-BD2F81C2B40CQ37642455-B9EB938C-3834-4539-BD2A-E885A88C2658Q37716645-6113EAB6-675A-4B63-A1E3-B9995072A81FQ37771250-39E449D0-41B6-4DF7-88BA-24607C2B27C9Q37975010-0BFCFFA7-645A-4123-A6C9-16493B5D3EB5
P2860
Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Randomized phase II study of p ...... Leukemia Group B trial 30407.
@ast
Randomized phase II study of p ...... Leukemia Group B trial 30407.
@en
type
label
Randomized phase II study of p ...... Leukemia Group B trial 30407.
@ast
Randomized phase II study of p ...... Leukemia Group B trial 30407.
@en
prefLabel
Randomized phase II study of p ...... Leukemia Group B trial 30407.
@ast
Randomized phase II study of p ...... Leukemia Group B trial 30407.
@en
P2093
P2860
P921
P356
P1476
Randomized phase II study of p ...... Leukemia Group B trial 30407.
@en
P2093
Jeffrey Bogart
Jennifer Garst
Lydia Hodgson
Ramaswamy Govindan
Robert Kratzke
Thomas Stinchcombe
Timothy Brotherton
Xiaofei Wang
P2860
P304
P356
10.1200/JCO.2010.33.4979
P407
P577
2011-07-11T00:00:00Z